Title : [vestigation of molecular factors determining BRAF-inhibitor sensitivity in solid tumors].

Pub. Date : 2020 Mar 17

PMID : 32181767






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Finally, in non-V600 BRAF mutant cell lines combined inhibition of pan-RAF and MEK with sorafenib/AZ628 and selumetinib showed significantly stronger cell growth, cell migration and Erk activation inhibition and also increased apoptosis induction compared to single treatments. Sorafenib zinc fingers and homeoboxes 2 Homo sapiens